Nanjing Zhongke Group Corp., Ltd.

home products Anti-Cancer Series Zhongke Ganoderma Lucidum Spore Capsule

Zhongke Ganoderma Lucidum Spore Capsule

Payment & Shipping Terms:

Minimum Order Quantity: 600 Barrel/Barrels bottles
Packaging Details: [Main material] 100% shell-broken Ganoderma Lucidum Spore [Suitable for] people with poor immunity, and cancer patients [Dosage] 2-5 capsules per time, three times a day [Specification] 0.15g/cap [Shelf life] 24 months [Government Approval No.] Weishijianzi (2003) No.0024 [Inner packing] 100caps X 0.15G/bottle [Gross weight] 65g [Packing for export] 200bottles /carton
Payment Terms: T/T

Detailed Product Description


  Zhongke pure physical shell-breaking technology of Ganoderma Lucidum spore at normal temperature(no additives) was discovered in 1997, what is advanced in it is that we put selected Ganoderma Lucidum spore powder in a container full of co2 and apply a series of physical technologies such as vibrating, rubbing, ultrasonic, etc. .To achieve complete shell-breaking without adding any additives such as acid, alkali, salt, Chinese traditional medicines, nano particles,etc.and without any heating or freezing ,ensuring 100%of pure Ganoderma Lucidum Spore content .

Zhongke Brand Ganoderma Lucidum Spore Capsule is the essence of ganoderma lucidum. Animal tests show that it can enhance the body's immunity and curb tumor growth. Reduce the pain of last period of tumor effectively. Reduce the toxin side effect of radiotherapy and chemotherapy, alleviate the hydrothorax, etc. It is of benefit to the weak and the elderly with poor immune function and cancer patients.

Zhongke Ganoderma Lucidum Spore Capsule Zhongke Ganoderma Lucidum Spore Capsule

Send your message to this supplier
« Prev Product 1 2 3 4 5 6 7 ... Next Product »

Other Products from this Supplier

Company Info

Nanjing Zhongke Group Corp., Ltd.
[China (Mainland)]
[Verified Member]

City: Nanjing
Province/State: Jiangsu
Country/Region : China (Mainland)

Business Type:Manufacturer

View Contact Details

Email this page Bookmark this page Print this Page